PatientsVille.com Logo

LOSS OF CONSCIOUSNESS and Hydroxyzine

PatientsVille

LOSS OF CONSCIOUSNESS Symptoms and Causes

Reye syndrome is a rare illness that can affect the blood, liver, and brain of someone who has recently had a viral infection. It always follows another illness. Although it mostly affects children and teens, anyone can get it. It can develop quickly and without warning. It is most common during flu season. Symptoms include

  • Nausea and vomiting
  • Listlessness
  • Personality change - such as irritability, combativeness or confusion
  • Delirium
  • Convulsions
  • Loss of consciousness

If these symptoms occur soon after a viral illness, seek medical attention immediately. Reye syndrome can lead to a coma and brain death, so quick diagnosis and treatment are critical. Treatment focuses on preventing brain damage. There is no cure.

The cause of Reye syndrome is unknown. Studies have shown that taking aspirin increases the risk of getting it. Because of that, health care professionals now recommend other pain relievers for young patients.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for LOSS OF CONSCIOUSNESS

LOSS OF CONSCIOUSNESS treatment research studies

Hydroxyzine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Hydroxyzine Side Effects

Completed Suicide (135)
Poisoning (62)
Cardiac Arrest (62)
Respiratory Arrest (57)
Death (29)
Toxicity To Various Agents (21)
Overdose (20)
Cardio-respiratory Arrest (18)
Nausea (17)
Anxiety (17)
Dizziness (17)
Somnolence (16)
Headache (16)
Exposure Via Ingestion (15)
Pyrexia (15)
Suicide Attempt (14)
Fall (14)
Pain In Extremity (13)
Pain (13)
Dyspnoea (13)
Condition Aggravated (12)
Confusional State (12)
Tremor (12)
Pruritus (12)
Abdominal Pain (11)
Depression (11)
Vomiting (11)
Fatigue (11)
Convulsion (10)
Asthenia (10)
Diarrhoea (10)
Feeling Abnormal (10)
Tachycardia (10)
Oedema Peripheral (10)
Injection Site Pain (10)
Balance Disorder (9)
Insomnia (9)
Dermatitis Exfoliative (9)
Syncope (9)
Torsade De Pointes (9)
Paraesthesia (8)
Grand Mal Convulsion (8)
Hypotension (8)
Septic Shock (8)
Urticaria (8)
Malaise (7)
Injury (7)
Pleural Effusion (7)
Psoriasis (7)
Myocardial Infarction (7)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Can you take this medicine with glaucoma

Hydroxozine hcl is working great to calm my nerves. But, I'm trying to decide if the joint pain is worth it. I believe I have a tic disorder, not anxiety. I've only had one dr visit and they are treating anxiety. But if I don't take roughly, 1200mg o

I took Mucinex DM 1200mg once at 10:30 pm and again at 10:30 am. By noon I wasnt functional at all, I had severe loss of focus, my eyes were dilated, and I was really slow, on top of the usual side effects of being jittery and nauseous. Since

I have been put on Molipaxin 3 weeks ago, I have dry mouth, hair loss and my panic attacks were showing no signs of improvement. Dr increased it to 100mg and put me onto Lamictin. I am not bi polar nor epileptic. My disorder ist algora phoebia. I a

leg cramps, hair loss Would it be better to take Lisinopril?

Have taken hydrea for a year because my spleen had increased in size. I have noticed increased loss of memory and some confusion for the past couple of months. I take 500 mg every other day and 1000 mg every other day.

I am having cramps, muscle pain, memory loss, I have been on Revlmid for about 1 year. Does anybody else my age have this disease, I am only 46 yr woman.

I have experienced weight loss of a pound a month for the last 2 years, since taking 100 mcg per day. My dr. can find no cause for this loss. I also have taken Metformin for about the same amount of time.

I have seen a significant loss of hair after about three months. I went to my dermatologist and told her that I feel that it is from Solodyn and she sent me to have blood work done thinking I may be anemic or I have a thyroid problem.

Anon- I would say the weed would cause the MOST memory loss used over time also depending on how strong it is ie, (haze, kush....dro...regs from 60's with seeds) THE STONGER it is the faster the brain cells go! As far as the valium/dia

<strong>Found Celepram effective at the end of the 3rd week. Effectiveness lasted for around 14 days. Following period i experienced continualled short term memory loss, hallucinations of seeing stars, skin irritated rash, shortness of breath &

3 months child red all over, staring, screaming high pitched cry, tracking red lines from injection site, lowered consciousness, screaming for more than 2 hours worse upon lying down. Would not breastfeed for 8 hours. Dosed exhuasted and awoke with h

LOSS OF CONSCIOUSNESS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score
Condition: Feeling Anxious
Interventions: Drug: Hydroxyzine;   Drug: Pregabalin;   Drug: Lactose
Outcome Measures: Efficacy treatment;   Efficacy of pregabaldin
2 Recruiting Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting
Condition: Pain
Interventions: Drug: Atarax (Hydroxyzine);   Drug: Placebo
Outcome Measures: Percentage of patients with pain relief (with a NRS score of 3/10 or lower);   pain score comparisons;   pain and anxiety comparisons;   comparison of adverse events;   patient and investigator satisfaction with analgesia;   assessment of post traumatic anxiety, stress and other related disorders
3 Recruiting Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry
Condition: Pain
Interventions: Drug: oral placebo;   Drug: Oral Analgesics
Outcome Measures: Improved sedation effectiveness based on numerical value for effectiveness as noted in description;   Difference in heart rate as measured by numerical delta value
4 Recruiting Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
Conditions: Placebo Effect;   Placebo Drug Interaction
Interventions: Drug: Hydroxizine;   Other: Placebo;   Drug: Hydroxyzine/placebo
Outcome Measures: Area-under-the-curve for drowsiness;   Area-under-the-curve for dryness of the mouth;   Mean percent of time of reporting drowsiness on a dichotomous scale.;   Mean percent of time of reporting dryness of mouth
5 Unknown  Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
Conditions: Critical Illness;   Mechanical Ventilation Complication
Interventions: Procedure: Enteral Sedation (EN);   Procedure: Control group: Intravenous Sedation (IV)
Outcome Measures: Percent of efficacy, measured by observed RASS = desired RASS ± 1.;   Sedation protocol effectiveness: percentage of "protocol violation days" on the total of ICU days.;   Delirium and coma free days (respectively negative CAM-ICU and RASS > - 3 in all daily observations until 28° ICU day) (11);   Ventilation free days (12);   Nursing evaluation of sedation adequacy (communication skills, cooperation, environment tolerance) (13);   Overall ICU and hospital mortality, absolute mortality after 1 year from ICU discharge.;   Sedative drugs costs.;   Indirect inefficacy markers
6 Unknown  Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence
Condition: Alcohol Dependence
Intervention: Drug: Prometa Treatment Program
Outcome Measures: The primary outcome measure is neurocognitive functioning as assessed by a battery of standardized neurocognitive tests that assess, executive functioning, verbal memory, general intelligence, and attention.;   Secondary outcome measures include, alcohol craving, subject retention, percent of abstinent days, percent of heavy drinking days, time to first heavy drinking day, and blood chemistries including liver enzymes, reports of side effects.
7 Recruiting Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Condition: Major Depressive Disorder
Interventions: Drug: ketamine venlafaxine;   Drug: Venlafaxine
Outcome Measure: Depressive state